Abstract

Making better use of available evidence on drugs and non-pharmacological therapies in the context of the COVID-19 pandemic is critical to minimizing suffering and saving lives. This debate aimed to present considerations about the concept of evidence, the hierarchy of evidence and the types of scientific evidence, seeking application in the context of the COVID-19 pandemic, with regard to the use of therapies for prevention and treatment of the disease. Initially, we made a brief introduction on the topic, highlighting the existence of doubts regarding the use of various drugs, as well as whether those available to combat other diseases can be safe and effective in the treatment of COVID-19. Then, we present some definitions about evidence, reinforcing that an exact definition depends on the context in which it will be used, and may even have a broad or restrictive connotation. Next, we mention that the evidence is classified in a hierarchical order, illustrated by means of a pyramid, according to the design of the study employed, one of the important markers to define the quality of the evidence. Emphasis is given to the evidence from the expert opinion, which is based on beliefs built on the basis of theory and non-systematic learning. Soon after, we resorted to basic concepts about three types of scientific evidence (direct, indirect and preliminary evidence) to explain the divergences between expert opinions. We conclude with comments and reflections on the need to define reasonably acceptable criteria for the use of evidence, for now available, in times of a pandemic, such as COVID-19.

Highlights

  • O uso de medicamentos e de outras terapias não farmacológicas para prevenir ou tratar doenças baseando-se nas melhores evidências científicas disponíveis obtidas por meio de pesquisas sistemáticas é amplamente aceito, tanto como uma boa prática clínica como para diretrizes e políticas em saúde

  • We present some definitions about evidence, reinforcing that an exact definition depends on the context in which it will be used, and may even have a broad or restrictive connotation

  • We mention that the evidence is classified in a hierarchical order, illustrated by means of a pyramid, according to the design of the study employed, one of the important markers to define the quality of the evidence

Read more

Summary

Ricardo de Souza KuchenbeckerII

Fazer o melhor uso das evidências disponíveis sobre medicamentos e terapias não farmacológicas no contexto da pandemia da COVID-19 é fundamental para minimizar os sofrimentos e salvar vidas. Este debate objetivou apresentar considerações sobre o conceito de evidência, hierarquia das evidências e os tipos de evidências científicas, buscando aplicação no contexto da pandemia da COVID-19, no que tange ao uso de terapias para prevenção e tratamento da doença. Recorremos a conceitos básicos sobre três tipos de evidências científicas (evidências diretas, indiretas e preliminares) para explicar as divergências entre opiniões de especialistas. Concluímos com comentários e reflexões sobre a necessidade de definir critérios razoavelmente aceitáveis para uso de evidências, por ora disponíveis, em tempos de pandemia, a exemplo da COVID-19. II Programa de Pós-graduação em Epidemiologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil

Estudo em animais
Análogo de nucleotídeos**
Preliminar Indireta
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.